Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform BOSTON and LONDON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage company …